SHELF LIFE EXTENDED - Visit the Check Expiration page to learn more.

Storage, Dosage and Administration

Storage, Dosage and Administration for
Johnson & Johnson's Janssen COVID-19 Vaccine

The Janssen COVID-19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID-19) in individuals 18 years of age and older. The emergency use of this product is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of the medical product under Section 564(b)(1) of the FD&C Act, unless the declaration is terminated or authorization revoked sooner.

How It's Supplied

The Janssen COVID-19 Vaccine is supplied in a carton of 10 multi-dose vials (NDC 59676-580-15). A maximum of 5 doses of 0.5 mL can be withdrawn from the multi-dose vial (NDC 59676-580-05). The vial stoppers are not made with natural rubber latex.

Storage and Handling*

Storage Prior to First Puncture of the Vaccine Vial

  • Store unpunctured multi-dose vials of the Janssen COVID-19 Vaccine at 36°F to 46°F (2°C to 8°C) and protect from light. Do not store frozen
  • Unpunctured vials of the vaccine may be stored between 47°F to 77°F (9°C to 25°C) for up to 12 hours

The Janssen COVID-19 Vaccine is initially stored frozen by the manufacturer, then shipped at 36°F to 46°F (2°C to 8°C). If vaccine is still frozen upon receipt, thaw at 36°F to 46°F (2°C to 8°C). If needed immediately, thaw at room temperature (maximally 77°F/25°C). Do not re-freeze once thawed.

  • At room temperature, a carton of 10 vials will take ~4 hours to thaw
  • At room temperature, an individual vial will take ~1 hour to thaw

Storage After First Puncture of the Vaccine Vial

  • After the first dose has been withdrawn, hold the vial between 36°F and 46°F (2°C to 8°C) for up to 6 hours or at room temperature (maximally 77°F/25°C) for up to 2 hours
  • Discard the vial if vaccine is not used within these times

Dose Preparation

  • The Janssen COVID-19 Vaccine is a colorless to slightly yellow, clear to very opalescent sterile suspension that does not contain a preservative
  • Visually inspect the Janssen COVID-19 Vaccine vials for particulate matter and discoloration prior to administration. If either of these conditions exist, do not administer the vaccine
  • Before withdrawing each dose of vaccine, carefully mix the contents of the multi-dose vial by swirling gently in an upright position for 10 seconds. Do not shake
  • Each dose is 0.5 mL. Each vial contains 5 doses. Do not pool excess vaccine from multiple vials
  • Record the date and time of first use on the Janssen COVID‑19 Vaccine vial label

As the vaccination provider, you must communicate to the recipient, or their caregiver, information consistent with the “Fact Sheet for Recipients and Caregivers” (and provide a copy or direct the individual to the website to obtain the Fact Sheet) prior to the individual receiving the Janssen COVID‑19 Vaccine.


  • Visually inspect each dose in the dosing syringe prior to administration
  • Verify the final dosing volume of 0.5 mL
  • Do not administer if vaccine is discolored or contains particulate matter
  • Administer the Janssen COVID-19 Vaccine intramuscularly
  • There is no information on the co-administration of the Janssen COVID-19 Vaccine with other vaccines

Provide a vaccination card to the recipient or their caregiver with the name of the vaccine (“Janssen COVID-19 Vaccine”) and date of administration to document vaccination.

Provide the v-safe information sheet to vaccine recipients/caregivers and encourage vaccine recipients to participate in v-safe. V-safe is a new voluntary smartphone-based tool that uses text messaging and web surveys to check in with people who have been vaccinated to identify potential side effects after COVID-19 vaccination. For more information, visit:

Ensuring the Authenticity of Johnson & Johnson's Janssen COVID-19 Vaccine

Johnson & Johnson and Janssen Pharmaceuticals are committed to identifying and mitigating the risks of counterfeit healthcare products. Information regarding how we address counterfeiting can be found at

The Janssen COVID-19 Vaccine is to be administered intramuscularly by a healthcare professional.

An authentic Janssen COVID-19 Vaccine includes the Janssen name and logo on the carton. The Janssen COVID-19 Vaccine is supplied in multi-dose vials. The vial stoppers are not made with natural rubber latex.

The Janssen COVID-19 Vaccine is never sold online and is distributed only through government channels. Janssen cannot verify the authenticity of products acquired outside of the legitimate supply chain. If you suspect the Janssen COVID-19 Vaccine you have may be counterfeit, contact us at 1-800-565-40081-800-565-4008 (US Toll Free) or 1-908-455-99221-908-455-9922 (US Toll).

COVID-19=coronavirus disease 2019; EUA=Emergency Use Authorization; FD&C Act=Federal Food, Drug, and Cosmetic Act.

Current as of July 12, 2021.

Important safety information

Important safety information